Paper42663285
Breaking the cycle of fibrosis: Ferroptosis as a therapeutic target (Review).
Feng X and 3 others. Int J Mol Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Breaking the cycle of fibrosis: Ferroptosis as a therapeutic target (Review). Papers, record 42663285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42663285
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Fibrosis | Major topic |
| Humans | |
| Animals | |
| Lipid Peroxidation | |
| Iron | |
| Signal Transduction | |
| Exosomes |
Source PubMed
References275
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37619958 | Ferroptosis of macrophages facilitates bone loss in apical periodontitis via NRF2/FSP1/ROS pathway. | Free Radic Biol Med | 2023 | https://conductscience.org/library/papers/37619958 | PubMed |
| 2 | 36746022 | The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36746022 | PubMed |
| 3 | 33128017 | Molecular and cellular mechanisms of liver fibrosis and its regression. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33128017 | PubMed |
| 4 | 38295662 | LuQi formula attenuates Cardiomyocyte ferroptosis via activating Nrf2/GPX4 signaling axis in heart failure. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38295662 | PubMed |
| 5 | 31534007 | Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis. | J Immunol | 2019 | https://conductscience.org/library/papers/31534007 | PubMed |
| 6 | 34370287 | The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis. | Adv Exp Med Biol | 2021 | https://conductscience.org/library/papers/34370287 | PubMed |
| 7 | 34978008 | Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/34978008 | PubMed |
| 8 | 38671262 | LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth. | Nat Cell Biol | 2024 | https://conductscience.org/library/papers/38671262 | PubMed |
| 9 | 38250467 | Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis. | J Clin Transl Hepatol | 2024 | https://conductscience.org/library/papers/38250467 | PubMed |
| 10 | 40001138 | Single-cell multi-omics analysis identifies SPP1+ macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy. | Biomark Res | 2025 | https://conductscience.org/library/papers/40001138 | PubMed |
| 11 | 29764521 | Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. | Cancer Commun (Lond) | 2018 | https://conductscience.org/library/papers/29764521 | PubMed |
| 12 | 36610517 | Mechanism of YY1 mediating autophagy dependent ferroptosis in PM2.5 induced cardiac fibrosis. | Chemosphere | 2023 | https://conductscience.org/library/papers/36610517 | PubMed |
| 13 | 30551460 | Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30551460 | PubMed |
| 14 | 37159329 | Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis. | FASEB J | 2023 | https://conductscience.org/library/papers/37159329 | PubMed |
| 15 | 36695612 | MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis. | Am J Transplant | 2023 | https://conductscience.org/library/papers/36695612 | PubMed |
| 16 | 38972525 | Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/38972525 | PubMed |
| 17 | 38471319 | Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38471319 | PubMed |
| 18 | 38056200 | Menstrual blood-derived stem cells exosomal miR-let-7 to ameliorate pulmonary fibrosis through inhibiting ferroptosis by Sp3/HDAC2/Nrf2 signaling pathway. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/38056200 | PubMed |
| 19 | 36356714 | IRF1/ZNF350/GPX4-mediated ferroptosis of renal tubular epithelial cells promote chronic renal allograft interstitial fibrosis. | Free Radic Biol Med | 2022 | https://conductscience.org/library/papers/36356714 | PubMed |
| 20 | 36921253 | Multifunctional Carbon-Based Nanoparticles: Theranostic Applications in Cancer Therapy and Diagnosis. | ACS Appl Bio Mater | 2023 | https://conductscience.org/library/papers/36921253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42663285
GET https://conductscience.org/api/papers/v1/42663285/references?page=2